AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31335301
Drug: Ethinylestradiol/levonorgestrel (EE/LNG)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethinylestradiol/levonorgestrel (EE/LNG) 30/150 μg co-administered with atazanavir/cobicistat (ATV/COBI) 300/150 mg
Trial: 28072447
Drug: Eicosapentaenoic acid-enriched
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid-enriched diet (ProSure®), 600 kcal with 2.2 g eicosapentaenoic acid, for 7 days before and 21 days after surgery
Trial: 26103654
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment + patient education
Trial: 18004124
Drug: Lamotrigine (100-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (100-400 mg/d)
Trial: 17453342
Drug: Tamoxifen treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen treatment for 2 years
Trial: 11472654
Drug: Immediate provisional
RxNorm normalized name: Clearskin Professional Daily Correcting
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate provisional protocol for single-tooth implant replacement
Trial: 31783004
Drug: Group B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B: 3.6 mL of articaine and 1 mL of dexamethasone (4‐mg/mL solution) with 1 mL of saline solution
Trial: 31783004
Drug: Group C:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C: 3.6 mL of articaine with 2 mL of dexamethasone (8‐mg/mL solution)
Trial: 31783004
Drug: Group A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A: 3.6 mL of articaine mixed with 2 mL of saline solution
Trial: 21267039
Drug: Caudal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal epidural injections with local anesthetic (lidocaine 0.5% 10 mL)
Trial: 21267039
Drug: Caudal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal epidural injections with 9 mL of 0.5% lidocaine mixed with 1 mL of steroid (either betamethasone [6 mg] or methylprednisolone [40 mg])
Trial: 17339189
Drug: Autologous peripheral
RxNorm normalized name: Autologous peripheral blood-derived CD34+ cells
DrugBank: Autologous peripheral blood-derived CD34+ cells (DB16367)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous peripheral blood stem cell transplantation (PBSCT) after induction and consolidation chemotherapy with BAVC regimen.
Trial: 17339189
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy with mitoxantrone, etoposide, and cytarabine (MICE) with or without G-CSF; consolidation therapy with mini-ICE.
Trial: 14668149
Drug: Biofeedback treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biofeedback treatment (EMG biofeedback training plus conventional exercise programme)
Trial: 7922793
Drug: Injectable calcitonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injectable calcitonin analogue ASC 710 (0.2 mg)
Trial: 7922793
Drug: Oral ASC
RxNorm normalized name: ASC-618
DrugBank: ASC-618 (DB18423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ASC 710 (20 mg)
Trial: 29151561
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment in community centers (n=29)
Trial: 23968366
Drug: Structured lifestyle
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured lifestyle and medication treatment by practice nurses with additional self‐monitoring
Trial: 23968366
Drug: Structured lifestyle
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured lifestyle and medication treatment by practice nurses without additional self‐monitoring
Trial: 23968366
Drug: Addition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addition of or dose change in lipid lowering or antihypertensive medications
Trial: 19100928
Drug: Continuous bladder
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous bladder catheterization (Group CC; n = 100)
Trial: 12769155
Drug: 2% polyvinylpyrrolidone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% polyvinylpyrrolidone (PVP) solution
Trial: 7517239
Drug: 0.9% NaCl
RxNorm normalized name: Trace Metals Additive in 0.9% NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% NaCl solution
Trial: 11081985
Drug: Standardized extract
RxNorm normalized name: Spring Valley Olive Leaf Standardized Extract 150mg Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized extract (SHA-10) of Andrographis paniculata fixed combination (Kan jang) taken three times daily for a minimum of 3 days and a maximum of 8 days (pilot study) or for exactly three days (phase III study)
Trial: 11081985
Drug: Standardized extract
RxNorm normalized name: Spring Valley Olive Leaf Standardized Extract 150mg Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized extract (SHA-10) of Andrographis paniculata fixed combination (Kan jang)
Trial: 10801250
Drug: Tamsulosin 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.6 mg
Trial: 9352698
Drug: Tamsulosin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin (all doses)
Trial: 4037540
Drug: Verapamil (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (10 mg bolus followed by continuous infusion)
Trial: 26995374
Drug: Metoprolol 25
RxNorm normalized name: metoprolol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 25 to 100 mg BID
Trial: 17727860
Drug: Rosuvastatin 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 80 mg/day
Trial: 17727860
Drug: Rosuvastatin and
RxNorm normalized name: rosuvastatin and ramipril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin and Atorvastatin (crossover treatment)
Trial: 15851919
Drug: bivalent rgp120
RxNorm normalized name: L1 protein, human papillomavirus type 16 vaccine
DrugBank: Human papillomavirus type 16 L1 capsid protein antigen (DB10301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bivalent rgp120 vaccine
Trial: 10799382
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (50 mg) with low-fat spread
Trial: 10799382
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (50 mg) with high-fat spread
Trial: 10799382
Drug: Alpha- plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha- plus beta-carotene (8 mg) with low-fat spread
Trial: 10799382
Drug: Alpha- plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha- plus beta-carotene (8 mg) with high-fat spread
Trial: 10799382
Drug: Lutein esters
RxNorm normalized name: lutein esters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein esters (8 mg lutein) with low-fat spread
Trial: 10799382
Drug: Lutein esters
RxNorm normalized name: lutein esters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein esters (8 mg lutein) with high-fat spread
Trial: 3904886
Drug: Indalpine 150
RxNorm normalized name: Indalpine
DrugBank: Indalpine (DB08953)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indalpine 150 mg per day
Trial: 3904886
Drug: Mianserin 60
RxNorm normalized name: mianserin 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mianserin 60 mg per day
Trial: 30105510
Drug: Lusutrombopag 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lusutrombopag 2 mg once daily for 7 days
Trial: 30105510
Drug: Lusutrombopag 3
RxNorm normalized name: lusutrombopag 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lusutrombopag 3 mg once daily for 7 days
Trial: 30105510
Drug: Lusutrombopag 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lusutrombopag 4 mg once daily for 7 days
Trial: 26704258
Drug: Epidural Cortical
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural Cortical Stimulation (CS) combined with intensive language therapy (3 hours a day for 6 weeks)
Trial: 26704258
Drug: Epidural Cortical
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural Cortical Stimulation (CS) combined with intensive language therapy
Trial: 20103451
Drug: Discount coupon
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discount coupon for oral contraceptive pills (OCPs)
Trial: 11152898
Drug: Oral ibuprofen
RxNorm normalized name: ibuprofen Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ibuprofen (800 mg) and topical benzocaine (20%)
Trial: 11152898
Drug: Oral placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral placebo and topical benzocaine (20%)
Trial: 11152898
Drug: Oral ibuprofen
RxNorm normalized name: ibuprofen Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ibuprofen (800 mg) and topical placebo
Trial: 11152898
Drug: Oral placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral placebo and topical placebo
Trial: 7981922
Drug: Investigated drugs
RxNorm normalized name: INVESTIGATIONAL THROMBOLYTIC DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigated drugs
Trial: 31494028
Drug: Morphine Parent/Nurse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine Parent/Nurse Controlled Analgesia (PNCA)
Trial: 31494028
Drug: Continuous Opioid
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous Opioid Infusion (COI)
Trial: 24748338
Drug: Cabergoline (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabergoline (0.5 mg tablets, twice per week for 12 weeks)
Trial: 24748338
Drug: LHRH agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LHRH agonist (decapeptyl, 3.75 mg subcutaneous, single injection, once a month for 3 months)
Trial: 15334276
Drug: Ciclopirox (Loprox)
RxNorm normalized name: Ciclopirox
DrugBank: Ciclopirox (DB01188)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciclopirox (Loprox) gel
Trial: 9024265
Drug: Cyclical hPTH-(1-34)
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclical hPTH-(1-34) + sequential calcitonin (75 U/day)
Trial: 27394381
Drug: Routine low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine low dose aspirin (LDA) 75 mg once daily from first trimester until 36-week gestation
Trial: 24495314
Drug: Gemigliptin/metformin sustained-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemigliptin/metformin sustained-release fixed-dose combination tablet (25/500 mg x 2 tablets) in high-fat fed state
Trial: 24495314
Drug: Gemigliptin/metformin sustained-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemigliptin/metformin sustained-release fixed-dose combination tablet (25/500 mg x 2 tablets) in fasted state
Trial: 8634878
Drug: Acrivastine 8
RxNorm normalized name: acrivastine 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acrivastine 8 mg + pseudoephedrine 60 mg (A + P)
Trial: 6378232
Drug: Low-dose acetylsalicylic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose acetylsalicylic acid (100 mg/day)
Trial: 30898204
Drug: Testosterone (1%)
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone (1%) gel for 12 weeks
Trial: 27128212
Drug: Tofacitinib (0.1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib (0.1, 0.3, 1, 3, 10, 30, 60, and 100 mg)
Trial: 10884257
Drug: Intravenous diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous diazepam (0.3 mg/kg)
Trial: 22097138
Drug: Xiaozhong Zhitong
RxNorm normalized name: METHYL SALICYLATE 13 g / MENTHOL 9 g / CAMPHOR (SYNTHETIC) 11 g TOPICAL PATCH [KGS Zhitong Gao Medicated Plaster Extra Strength]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xiaozhong Zhitong mixture (50 ml every time, twice a day for 4 weeks)
Trial: 22097138
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg every time, twice a day)
Trial: 22097138
Drug: Sham group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham group (no preventing treatment)
Trial: 19186712
Drug: Acupuncture therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture therapy combined with tropisetron (5 mg daily for 6 days)
Trial: 19186712
Drug: Sham acupuncture
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham acupuncture combined with tropisetron (5 mg daily for 6 days)
Trial: 8832449
Drug: PCA morphine
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCA morphine with D = 1 mg, LI = 6 min (Group 1‐6)
Trial: 8832449
Drug: PCA morphine
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCA morphine with D = 1.5 mg, LI = 9 min (Group 1.5‐9)
Trial: 8832449
Drug: PCA morphine
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCA morphine with D = 2 mg, LI = 12 min (Group 2‐12)
Trial: 8310977
Drug: Amlodipine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (mean daily dose 8.8 mg)
Trial: 8310977
Drug: Atenolol (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (mean daily dose 83.7 mg)
Trial: 30725077
Drug: Youth‐Nominated Support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Youth‐Nominated Support Team Intervention (YST) plus Treatment as Usual (TAU)
Trial: 30004900
Drug: Intravenous lipid
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous lipid emulsion (ILE) 5.25 mL/kg
Trial: 17342480
Drug: Nevirapine 200
RxNorm normalized name: nevirapine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nevirapine 200 mg once daily for 7 days
Trial: 8632075
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg once daily for 7 days
Trial: 17342480
Drug: Nevirapine 200
RxNorm normalized name: nevirapine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nevirapine 200 mg combined with itraconazole 200 mg once daily for 7 days
Trial: 16359503
Drug: Clopidogrel 75
RxNorm normalized name: clopidogrel 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 75 mg day(-1)
Trial: 11824492
Drug: Single-family behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-family behavioral family therapy (BFT)
Trial: 9551874
Drug: Diltiazem 180
RxNorm normalized name: diltiazem 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 180 mg-360 mg
Trial: 28142344
Drug: NTS group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NTS group (three-site injection technique)
Trial: 28142344
Drug: SSI group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SSI group (single-site injection technique)
Trial: 26429605
Drug: Vancomycin (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin (mean 12.8 mg/kg every 12 hours for 7 patients, every 8 hours for 1 patient, every 24 hours for 1 patient)
Trial: 21603891
Drug: Oxycodone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone (10 mg) + Ethanol (0.3 g/kg)
Trial: 7904786
Drug: Ethanol (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.3 g/kg)
Trial: 21603891
Drug: Oxycodone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone (10 mg) + Ethanol (0.6 g/kg)
Trial: 21603891
Drug: Active drug
RxNorm normalized name: Capillary active drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active drug conditions (Oxycodone and Ethanol)
Trial: 19394894
Drug: Lapatinib 1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib 1500 mg once daily
Trial: 18458039
Drug: Lapatinib 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib 500 mg twice daily
Trial: 18458039
Drug: Lapatinib (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib (both dosing schedules)
Trial: 12973963
Drug: Propofol alone
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol alone (1.5 mg/kg)
Trial: 12973963
Drug: Combined propofol-sevoflurane
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined propofol-sevoflurane (1.5 mg/kg propofol followed by 5% sevoflurane in oxygen)
Trial: 9223888
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 3 l.min‐1 oxygen via a mask for initial 3 hours
Trial: 8429447
Drug: Beclomethasone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone (50 micrograms nebulized, 3 doses per day for 28 days)
Trial: 8429447
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (placebo, 3 doses per day for 28 days)
Trial: 31868565
Drug: 10% urea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% urea cream
Trial: 30415610
Drug: Low-dose methotrexate
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose methotrexate (15 to 20 mg weekly)
Trial: 27922745
Drug: Linezolid 600
RxNorm normalized name: linezolid 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid 600 mg q.12h
Trial: 27922745
Drug: Linezolid 600
RxNorm normalized name: linezolid 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid 600 mg q.8h
Trial: 24949292
Drug: Heparin (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (1000 IU)
Trial: 14738234
Drug: Inhaled formoterol
RxNorm normalized name: formoterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled formoterol (18 microg)
Trial: 6105907
Drug: Flunitrazepam 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam 0.05 mg . kg‐1
Trial: 6105907
Drug: Thiopentone 6.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone 6.0 mg . kg‐1
Trial: 28045137
Drug: L. plantarum
RxNorm normalized name: Lactobacillus acidophilus/L. plantarum/Bifido no.7 15 billion cell ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. plantarum TIFN101
Trial: 28045137
Drug: L. plantarum
RxNorm normalized name: Lactobacillus acidophilus/L. plantarum/Bifido no.7 15 billion cell ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. plantarum WCFS1
Trial: 28045137
Drug: L. plantarum
RxNorm normalized name: Lactobacillus acidophilus/L. plantarum/Bifido no.7 15 billion cell ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. plantarum CIP104448
Trial: 23953270
Drug: quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: quetiapine XR (400-800 mg)
Trial: 23953270
Drug: risperidone (2-6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: risperidone (2-6 mg)
Trial: 19639375
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion rate of 50 microg x kg(‐1) x min(‐1)
Trial: 19639375
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion rate of 100 microg x kg(‐1) x min(‐1)
Trial: 19639375
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion rate of 150 microg x kg(‐1) x min(‐1)
Trial: 19639375
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion rate of 120 microg x kg(‐1) x min(‐1)
Trial: 19639375
Drug: Predicted infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Predicted infusion rate to achieve a mean concentration of 5 microg x mL(‐1)
Trial: 16798042
Drug: Doxycycline-rifampin-amikacin (ADR)
RxNorm normalized name: Amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Doxycycline-rifampin-amikacin (ADR) regimen: doxycycline 100 mg twice a day, rifampin 10 mg/kg body weight/day every morning for eight weeks, plus 7.5 mg/kg amikacin intramuscularly twice a day for seven days.
Trial: 16798042
Drug: Doxycycline-rifampin (DR)
RxNorm normalized name: Rifampin
DrugBank: Rifampin (DB01045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline-rifampin (DR) regimen: doxycycline 100 mg twice a day and rifampin 10 mg/kg body weight/day every morning for eight weeks.
Trial: 11896119
Drug: Bolus doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus doxorubicin (30 mg/m2 every 3 weeks for a total of 360 mg/m2)
Trial: 11896119
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of doxorubicin (360 mg/m2 over 48 hours)
Trial: 11896119
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Bolus and Continuous infusion)
Trial: 23084955
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy (ET)